Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 22, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-06
DOI
10.1007/s11912-020-0867-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
- (2019) Daniel R. Gomez et al. JOURNAL OF CLINICAL ONCOLOGY
- NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).
- (2019) Steven J. Chmura et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
- (2019) David A Palma et al. LANCET
- Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists
- (2019) Elysia Donovan et al. Breast Journal
- Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
- (2019) Joshua M. Bauml et al. JAMA Oncology
- The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
- (2018) N. Andratschke et al. BMC CANCER
- Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base
- (2018) Nasreen A. Vohra et al. Breast Journal
- Locoregional control and survival after lymph node SBRT in oligometastatic disease
- (2018) Mauro Loi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry
- (2018) Anand Mahadevan et al. Radiation Oncology
- Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial
- (2018) Marco Trovo et al. RADIOTHERAPY AND ONCOLOGY
- Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
- (2018) Laura Vera-Ramirez et al. Nature Communications
- Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
- (2018) Sean P. Pitroda et al. Nature Communications
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
- (2018) Puneeth Iyengar et al. JAMA Oncology
- TREATMENT OUTCOMES OF BREAST CANCER LIVER METASTASIS TREATED WITH STEREOTACTIC BODY RADIOTHERAPY
- (2018) Cem Onal et al. BREAST
- Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer
- (2018) Xiu-Mei Bai et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer
- (2018) DIRK RADES et al. ANTICANCER RESEARCH
- DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs
- (2018) Go Oshima et al. CANCER RESEARCH
- Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
- (2018) Yi-bin Xiao et al. Journal of Zhejiang University-SCIENCE B
- Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
- (2018) Marta Scorsetti et al. Radiation Oncology
- Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery
- (2017) Jana Barinoff et al. EUROPEAN JOURNAL OF CANCER
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical study of radiofrequency ablation combined with TACE in the treatment of breast cancer with liver metastasis
- (2017) Haijun Wang et al. Oncology Letters
- Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer
- (2017) Li-Ming Xu et al. Scientific Reports
- The safety and effectiveness of liver resection for breast cancer liver metastases: A systematic review
- (2016) Katherine Fairhurst et al. BREAST
- Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
- (2015) Max Seidensticker et al. BMC CANCER
- Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease
- (2015) I S Bhattacharya et al. BRITISH JOURNAL OF RADIOLOGY
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- (2015) P. K. Brastianos et al. Cancer Discovery
- 14q32-encoded microRNAs mediate an oligometastatic phenotype
- (2015) Abhineet Uppal et al. Oncotarget
- Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs
- (2014) Abhineet Uppal et al. CLINICAL & EXPERIMENTAL METASTASIS
- Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients
- (2013) P. Mariani et al. EJSO
- Selection and adaptation during metastatic cancer progression
- (2013) Christoph A. Klein NATURE
- Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
- (2013) Omar M. Rashid et al. SURGERY
- Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
- (2012) Yves A. Lussier et al. PLoS One
- A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
- (2012) Ingrid Fumagalli et al. Radiation Oncology
- Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
- (2011) Robert C. G. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Surgical Approach to Pulmonary Metastases from Breast Cancer
- (2011) Witold Kycler et al. Breast Journal
- Stereotactic body radiotherapy for multisite extracranial oligometastases
- (2011) Joseph K. Salama et al. CANCER
- Hepatic resection for metastatic breast cancer: A systematic review
- (2011) Terence C. Chua et al. EUROPEAN JOURNAL OF CANCER
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
- (2011) Michael T. Milano et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MicroRNA Expression Characterizes Oligometastasis(es)
- (2011) Yves A. Lussier et al. PLoS One
- Resection of liver metastases from breast cancer: Towards a management guideline
- (2011) Mohammad Howlader et al. International Journal of Surgery
- Clinical features of surgical resection for pulmonary metastasis from breast cancer
- (2008) F. Chen et al. EJSO
- Pulmonary metastases of breast cancer. When is resection indicated?
- (2008) Stefan Welter et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
- (2007) Michael T. Milano et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now